
|Articles|January 1, 2004
532-nm laser adds option to skin rejuvenation
Summit, NJ - A long-pulse 532-nm frequency-doubled Nd:YAG laser (DioLite Laser, Iridex) offers another safe and effective alternative for nonablative facial skin rejuvenation in appropriately selected patients, according to the results of a randomized, split-face clinical trial conducted by Paul J. Carniol, M.D.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Medicus Pharma Completes Phase 2 Enrollment of D-MNA Study to Non-Invasively Treat BCC
2
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
3
Phase 2 Nemolizumab Trial Opens for CPUO
4
Balancing Pathophysiology and Patient Lifestyle in Acne Management: Part 1
5


















